BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8637040)

  • 1. Pancreatic cancer shows modest survival gain.
    Bankhead C
    J Natl Cancer Inst; 1996 Jun; 88(12):784-6. PubMed ID: 8637040
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic cancer.
    Yeo TP; Hruban RH; Leach SD; Wilentz RE; Sohn TA; Kern SE; Iacobuzio-Donahue CA; Maitra A; Goggins M; Canto MI; Abrams RA; Laheru D; Jaffee EM; Hidalgo M; Yeo CJ
    Curr Probl Cancer; 2002; 26(4):176-275. PubMed ID: 12399802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pancreatic cancer].
    Hovendal CP; Jensen TS
    Ugeskr Laeger; 2002 Jun; 164(23):3040-2. PubMed ID: 12082856
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
    Kawaida H; Fujii H
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
    [No Abstract]   [Full Text] [Related]  

  • 5. Current diagnosis and treatment of pancreatic cancer in China.
    Guo X; Cui Z
    Pancreas; 2005 Jul; 31(1):13-22. PubMed ID: 15968242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocytes and pancreatic cancer: the effects of these cells on diagnosis and patient survival.
    Pezzilli R; Fabbri D; Imbrogno A
    JOP; 2011 Mar; 12(2):209-10. PubMed ID: 21386655
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic cancer: new strategies available, but long battle ahead.
    Parvez T; Dawood T
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):303-4. PubMed ID: 12814523
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment for pancreatic cancer.
    Held-Warmkessel J; Volpe H; Waldman AR
    Clin J Oncol Nurs; 1998 Oct; 2(4):127-34. PubMed ID: 10232158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Cancer: A Time to Change.
    Ferrone CR; Ryan DP
    Ann Surg; 2020 Jun; 271(6):1003-1004. PubMed ID: 32398612
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment trend for pancreas cancer].
    Shimada H
    Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):163. PubMed ID: 16878406
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy improves overall survival in pancreatic cancer.
    Mayor S
    Lancet Oncol; 2015 Feb; 16(2):e58. PubMed ID: 25601339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer.
    Koido S; Homma S; Takahara A; Namiki Y; Komita H; Uchiyama K; Ito M; Gong J; Ohkusa T; Tajiri H
    Immunotherapy; 2012 Jan; 4(1):5-7. PubMed ID: 22149993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pancreatic cancer- a curable disease].
    Limani P; Samaras P; Lesurtel M; Graf R; DeOliveira ML; Petrowsky H; Clavien PA
    Praxis (Bern 1994); 2015 Apr; 104(9):453-60. PubMed ID: 25900693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of circulating dendritic cells in patients with unresectable pancreatic cancer.
    Hirooka S; Yanagimoto H; Satoi S; Yamamoto T; Toyokawa H; Yamaki S; Yui R; Inoue K; Michiura T; Kwon AH
    Anticancer Res; 2011 Nov; 31(11):3827-34. PubMed ID: 22110205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
    Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
    Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant treatment of pancreatic cancer].
    Michalski CW; Kleeff J; Jäger D; Friess H; Büchler MW
    Dtsch Med Wochenschr; 2007 Apr; 132(15):803-7. PubMed ID: 17427090
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s.
    Ozaki H
    Int J Pancreatol; 1992 Aug; 12(1):5-9. PubMed ID: 1527450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.